DeHeng Advised Poly Pharm on the IPO Project on the GEM

2017-04-05

Recently, Hainan Poly Pharmaceutical Co., Ltd. ("Poly Pharm") was officially listed on the ChiNext of Shenzhen Stock Exchange, with the stock abbreviation of "Poly Pharm" and the stock code of "300630". Poly Pharm issued 30,529,405 shares through this IPO and raised funds of 350,782,863.45 yuan. DeHeng Hangzhou Office provided high-quality legal services for this listing.

Established in July 1992 and headquartered in Haikou, Poly Pharm is a high-tech enterprise specialized in research and development, production and sale of drugs. Poly Pharm is certified as a pioneer enterprise for drug preparation internationalization by Chinese pharmaceutical enterprises and is named the outstanding pharmaceutical enterprise in the pharmaceutical industry in Hainan Province. The company's main products, desloratadine tablets (state-level torch program project), desloratadine dry suspension (high-tech product in Hainan Province), and "production and transformation of diclofenac sodium enteric-coated sustained release capsules" project won the second prize for Hainan Provincial Science and Technology Award. "Development and industrialization of desloratadine dry suspension" project won the third prize for Hainan Provincial Science and Technology Award; "Desloratadine Dispersible Tablets (desloratadine dry suspension)" was rated as an outstanding product in the pharmaceutical industry in Hainan Province by Hainan Province Pharmaceutical Industry Association; desloratadine dispersible tablets and desloratadine dry suspension ranked among the brand list of hospital terminal and community-level terminal under the 2016 China Pharmaceutical Brand List (anti-allergy medicine category) at the "28th China Medicine Economic Information Conference". The successful listing of Poly Pharm will not only consolidate the company's advantageous position in the pharmaceutical industry, but also build a greater capital operation platform for Poly Pharm.

The project team that consists of Zhang Lihao, Xia Yongjun, and Zhang Xin who are the partners of DeHeng Hangzhou Office and lawyers Zhang Lina et al. provided efficient and professional legal services for the IPO of Poly Pharm and its listing on ChiNext. The customer spoke highly of the project team.